Member of the Association of American Physicians
Michael D. Jensen focuses on Internal medicine, Endocrinology, Adipose tissue, Obesity and Lipolysis. Michael D. Jensen combines subjects such as Diabetes mellitus and Gene expression with his study of Internal medicine. Much of his study explores Endocrinology relationship to Fatty acid.
His Adipose tissue study integrates concerns from other disciplines, such as Senolytic, Abdomen and Fatty acid metabolism. His study looks at the relationship between Obesity and fields such as Body mass index, as well as how they intersect with chemical problems. His Weight loss research includes elements of Weight gain, Thermogenesis, Obstructive sleep apnea, Physical exercise and Type 2 Diabetes Mellitus.
Michael D. Jensen mostly deals with Internal medicine, Endocrinology, Adipose tissue, Obesity and Insulin. His work deals with themes such as Diabetes mellitus and Type 2 diabetes, which intersect with Internal medicine. His study brings together the fields of Fatty acid and Endocrinology.
The various areas that Michael D. Jensen examines in his Fatty acid study include Meal, Very low-density lipoprotein and Triglyceride. His studies in Adipose tissue integrate themes in fields like Inflammation, Splanchnic, CD36 and Fatty acid metabolism. His Obesity research includes themes of Basal metabolic rate, Weight gain, Physical therapy and Surgery.
His main research concerns Internal medicine, Endocrinology, Adipose tissue, Obesity and Fatty acid. His study explores the link between Internal medicine and topics such as Type 2 diabetes that cross with problems in Randomized controlled trial. His Insulin resistance, Insulin, Lipolysis and White adipose tissue study in the realm of Endocrinology interacts with subjects such as Context.
His Adipose tissue course of study focuses on Proinflammatory cytokine and Systemic inflammation. In his study, which falls under the umbrella issue of Obesity, Gastric bypass surgery is strongly linked to Surgery. His research in Fatty acid intersects with topics in Lipid metabolism, Lipoprotein lipase and Bolus.
His primary areas of investigation include Internal medicine, Endocrinology, Obesity, Adipose tissue and Body mass index. His work deals with themes such as Ceramide and Mitochondrion, which intersect with Internal medicine. His research investigates the connection between Endocrinology and topics such as Fatty acid that intersect with issues in CD36.
His biological study spans a wide range of topics, including Weight gain, Disease and Type 2 diabetes. Michael D. Jensen combines subjects such as Randomized controlled trial and Surgery with his study of Type 2 diabetes. His Adipose tissue research is multidisciplinary, incorporating elements of Inflammation, Senescence, Senolytic and Leptin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Bariatric Surgery: A Systematic Review and Meta-analysis
Henry Buchwald;Yoav Avidor;Eugene Braunwald;Michael D. Jensen.
JAMA (2004)
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
Michael D. Jensen;Donna H. Ryan;Caroline M. Apovian;Jamy D. Ard.
Circulation (2014)
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Henry Buchwald;Rhonda Estok;Kyle Fahrbach;Deirdre Banel.
The American Journal of Medicine (2009)
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Michael D. Jensen;Donna H. Ryan;Caroline M. Apovian;Jamy D. Ard.
Circulation (2014)
Role of Nonexercise Activity Thermogenesis in Resistance to Fat Gain in Humans
James A. Levine;Norman L. Eberhardt;Michael D. Jensen.
Science (1999)
Splanchnic lipolysis in human obesity
Soren Nielsen;Zeng Kui Guo;C. Michael Johnson;Donald D. Hensrud.
Journal of Clinical Investigation (2004)
Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes.
Thierry Thomas;Francesca Gori;Sundeep Khosla;Michael D. Jensen.
Endocrinology (1999)
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
André J Scheen;Nick Finer;Priscilla Hollander;Michael D Jensen.
The Lancet (2006)
Interindividual variation in posture allocation: possible role in human obesity.
James A. Levine;Lorraine M. Lanningham-Foster;Shelly K. McCrady;Alisa C. Krizan.
Science (2005)
Influence of body fat distribution on free fatty acid metabolism in obesity
M. D. Jensen;M. W. Haymond;R. A. Rizza;Philip Cryer.
Journal of Clinical Investigation (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
University of Padua
Aarhus University Hospital
Google (United States)
University of Porto
Hanyang University
Chinese Academy of Sciences
Federal University of Toulouse Midi-Pyrénées
Centre national de la recherche scientifique, CNRS
University of Tübingen
Vita-Salute San Raffaele University
Broad Institute
Ehime University
National Institutes of Health
Helmholtz Centre for Environmental Research
Florida Department of Environmental Protection
University of Virginia
University College London
KU Leuven